MLEC

6-K - Moolec Science SA (0001937737) (Filer)

3 - Moolec Science SA (0001937737) (Issuer)

WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced a significant scientific breakthrough in the production of animal proteins in plants.Through a sponsored research project with one of the most prestigious academic institutions in the United States of America, Moolec has successfully demonstrated the stable expression of bovine myoglobin, a heme-containing protein, within the seeds of the common pea (Pisum sativum).Platform Expansion: A New Cr

6-K - Moolec Science SA (0001937737) (Filer)

3 - Moolec Science SA (0001937737) (Issuer)

3 - Moolec Science SA (0001937737) (Issuer)

3 - Moolec Science SA (0001937737) (Issuer)

3 - Moolec Science SA (0001937737) (Issuer)

3 - Moolec Science SA (0001937737) (Issuer)

3 - Moolec Science SA (0001937737) (Issuer)

3 - Moolec Science SA (0001937737) (Issuer)

3 - Moolec Science SA (0001937737) (Issuer)

6-K - Moolec Science SA (0001937737) (Filer)

WARWICK, UK / ACCESS Newswire / February 13, 2026 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC)("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced positive results from the crushing process of its U.S. GLASO1 safflower platform, confirming gamma-linolenic acid ("GLA") concentrations of approximately 45%.The results follow the successful completion of Moolec's 2025 U.S. GLASO1 safflower campaign and represent a major operational milestone, validating the Company's ability to deliver commercial-scale agricultural and industrial performa

6-K - Moolec Science SA (0001937737) (Filer)

GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / January 30, 2026 / Moolec Science S.A. ("Moolec" or the "Company"), a science-based food ingredient company focused on scalable protein solutions for the global market, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to certain conditions.The Panel acknowledged that the Company satisfied the minimum bid price compliance period under Nasdaq Listing Rule 5550(b)(2) on January 16, 2026, following the effectiveness of its reverse stock split on January 5, 2026. The Panel will retain jurisdiction over the bid price matter through May 13, 2026, in

6-K - Moolec Science SA (0001937737) (Filer)

GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / January 23, 2026 / Moolec Science S.A. ("Moolec" or the "Company") today announced that Nasdaq Staff has issued a memorandum to the Nasdaq Hearings Panel (the "Panel") concluding that there is sufficient basis to grant Moolec an exception through June 29, 2026 to demonstrate compliance with the stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Requirement"), subject to certain disclosure conditions.The Staff memo reflects Nasdaq's acknowledgment of the material improvement in Moolec's balance sheet following a series of accounting and corporate events completed during the fourth quarter of 2

6-K - Moolec Science SA (0001937737) (Filer)

GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / January 22, 2026 / Moolec Science S.A. ("Moolec" or the "Company") today announced that it has received a decision from the Nasdaq Hearings Panel (the "Panel") granting the Company an exception through June 29, 2026 to demonstrate compliance with the stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Requirement"), subject to certain disclosure conditions.Following bankruptcy proceedings of certain of Moolec's subsidiaries as described below, Moolec has been able to recognize a gain related to the derecognition of such subsidiaries.On December 26, 2025, Bioceres S.A. filed for bankruptcy befo

6-K - Moolec Science SA (0001937737) (Filer)

GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / January 5, 2026 / Moolec Science SA ("Moolec" or the "Company") today announced that, in accordance with the resolutions passed at the extraordinary general meeting of shareholders held on December 16, 2025, and the resolutions adopted by the Company's board of directors on December 19, 2025, the Company has consummated, effective as of January 5, 2026, the previously announced share consolidation at a ratio of 15-for-1, so that all shareholders holding every 15 ordinary shares of par value of US$0.10 each will hold 1 ordinary share of par value US$1.50 each (the "Share Consolidation").As a result, every 15 ordinary shares of the Company, par v

GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / December 31, 2025 / Moolec Science SA ("Moolec" or the "Company") received an additional determination letter (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company does not currently meet the minimum stockholders' equity requirement of $2.5 million under Nasdaq Listing Rule 5550(b)(1).As previously disclosed in the Company's Form 20-F for the year ended June 30, 2025, management expects to regain compliance with the Nasdaq continued listing standards through the recognition of an estimated gain of approximately $105.8 million related to the derecognition of certain subsid

6-K - Moolec Science SA (0001937737) (Filer)

6-K - Moolec Science SA (0001937737) (Filer)